News

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...